After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jan 17, 2020 at 12:32 PM.

  1. #1 cafead, Jan 17, 2020 at 12:32 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,051
    Likes Received:
    3
    via China-based cancer and autoimmune disease biotech I-Mab Biopharma has raised $104 million on the U.S. Nasdaq composite.

    article source
     
    Quote

Reply to Thread